SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VBroady who wrote (4385)10/17/1998 9:59:00 AM
From: Prospector  Read Replies (1) of 5402
 
Welcome VBroady..

1. Dr Drees says he will be the first human trial volunteer...

2. Small & new company.. Yes this company is very small... but the players are vetarins... Dr Drees was CEO of Green Cross who took Fluosol to FDA approval... PHER-02 is a update version of Fluosol.(Second Generation)

3. A new drug takes 10 to 20 years to get FDA approval.. Dr Drees says PHER-02 will probably take 3 years..

4. Exciting .... YES.... high risk.... according to DR Drees he says it works,,,, we'll have to see..

5 Fortune..... YES>>> YES YES......if it works.

6. BUY OUT.... OR Partnership.... YES..in my opinion... The big boys are watchin now.. They already know the outcome... All the players from all the companys in this field know each other.. They know what is going on..

7. 50% move... LOL just a few pennies,,, wait till somethin big happens.. pennies....LOL... Day traders move in and out wait till the big boys start buyin... down the road....

Prospector
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext